NASDAQ Biotechnology Total Retu XNBI Indice
4598.99 USD
{{ price }}
0.187158%
{{change_pct}}%
PAESE
stati Uniti
Borsa valori
Nasdaq GIDS
MIN - MAX [24 ore]
4576.85
-
4611.78 USD
Numero di componenti
190
NASDAQ Biotechnology Total Retu Grafico dei prezzi
Top 5 Vincitori delle Ultime 24 Ore
| XBIT | XBiotech | +7.89% | |
|---|---|---|---|
| DBVT | DBV | +6.72% | |
| PACB | Pacific Biosciences of California | +5.74% | |
| INCY | Incyte | +4.83% | |
| VNDA | Vanda Pharmaceuticals | +4.56% |
Top 5 Perdenti delle Ultime 24 Ore
| EGRX | Eagle Pharmaceuticals | -17.56% | |
|---|---|---|---|
| FGEN | FibroGen | -7.18% | |
| OMER | Omeros | -5.14% | |
| SGMO | Sangamo Therapeutics | -4.24% | |
| CGEN | Compugen | -3.55% |
NASDAQ Biotechnology Total Retu XNBI PANORAMICA FINANZIARIA E DI TRADING
| NASDAQ Biotechnology Total Retu Prezzo dell'Indice | 4598.99 USD |
| Chiusura Precedente | 4472.96 USD |
| Apertura | 4476.26 USD |
| Prezzo di Acquisto | 0 USD x 0 |
| Prezzo di Vendita | 0 USD x 0 |
| Variazione Giornaliera | 4464.53 - 4532.84 USD |
| Variazione a 52 Settimane | 4464.53 - 4532.84 USD |
| Volume | 0 USD |
| Volume Medio | N/A |
Informazioni di trading
NASDAQ Biotechnology Total Retu Storico dei prezzi dell'Indice
| Massimo a 52 Settimane | 4532.84 USD |
| Minimo a 52 Settimane | 4464.53 USD |
| Media Mobile a 50 Giorni | N/A |
| Media Mobile a 200 Giorni | N/A |
XNBI Statistiche dell'indice
| Volume Medio (3 Mesi) | N/A |
| Vol. Medio Giornaliero (10 Giorni) | N/A |
D&R per l'Indice NASDAQ Biotechnology Total Retu
Qual è il prezzo attuale dell'Indice XNBI?
Il prezzo dell'Indice NASDAQ Biotechnology Total Retu XNBI oggi è di 4598.99 USD.
Come acquistare l'Indice NASDAQ Biotechnology Total Retu?
Puoi acquistare l'indice XNBI sulla borsa Nasdaq GIDS. Contatta il tuo consulente finanziario per selezionare un broker.
Qual è la sigla borsistica dell'Indice NASDAQ Biotechnology Total Retu?
La sigla (o ticker) dell'Indice NASDAQ Biotechnology Total Retu è XNBI.
Quanti componenti contiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu contiene 190 componenti.
A quale paese appartiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu fa riferimento a United States.
A quale borsa appartiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu fa riferimento alla borsa Nasdaq GIDS.
NASDAQ Biotechnology Total Retu COMPONENTI
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
|---|
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Amgen AMGN | $279.11 — |
-0.44
|
$150.08B — | $2.99M — | $277.75 — | $286.17 — | $150.08B — | 25.44 | $10.97 — |
| Gilead Sciences GILD | $107.62 — |
+1.6
|
$133.87B — | $6.3M — | $105.79 — | $107.86 — | $133.87B — | 22.60 | $4.76 — |
| Vertex Pharmaceuticals Incorporated VRTX | $443.4 — |
-0.54
|
$113.86B — | $1.17M — | $441.13 — | $446.18 — | $113.86B — | 0 | -$3.81 — |
| Regeneron Pharmaceuticals REGN | $521 — |
+0.14
|
$56.25B — | $964.85K — | $514.79 — | $524.52 — | $56.25B — | 13.24 | $39.34 — |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — |
| Alnylam Pharmaceuticals ALNY | $318.25 — |
-1.15
|
$41.5B — | $663.9K — | $315 — | $325 — | $41.5B — | 0 | -$2.1 — |
| Insmed Incorporated INSM | $101.74 — |
-2.97
|
$19.33B — | $3.95M — | $101.14 — | $105.8 — | $19.33B — | 0 | -$5.93 — |
| Biogen BIIB | $126.92 — |
-0.31
|
$18.6B — | $862.17K — | $126.46 — | $129.1 — | $18.6B — | 12.54 | $10.12 — |
| Illumina ILMN | $94.16 — |
+1
|
$14.91B — | $2.93M — | $92.76 — | $95.99 — | $14.91B — | 0 | -$6.08 — |
| Incyte INCY | $70.81 — |
+4.83
|
$13.71B — | $3.02M — | $69.84 — | $71.5 — | $13.71B — | 354.05 | $0.2 — |
| United Therapeutics UTHR | $284.09 — |
-0.66
|
$12.81B — | $357.51K — | $283.52 — | $288.99 — | $12.81B — | 11.31 | $25.11 — |
| Neurocrine Biosciences NBIX | $126.71 — |
-0.84
|
$12.54B — | $476.36K — | $126.2 — | $128.66 — | $12.54B — | 42.95 | $2.95 — |
| Exelixis EXEL | $43.09 — |
-1.01
|
$11.75B — | $2.68M — | $42.66 — | $43.87 — | $11.75B — | 19.67 | $2.19 — |
| Qiagen QGEN | $48.04 — |
+1.24
|
$10.4B — | $1.21M — | $47.74 — | $48.36 — | $10.4B — | 111.72 | $0.43 — |
| BioMarin Pharmaceutical BMRN | $54.1 — |
-0.07
|
$10.38B — | $1.42M — | $53.76 — | $54.55 — | $10.38B — | 20.03 | $2.7 — |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — |
| Blueprint Medicines BPMC | $128.15 — |
-0.08
|
$8.29B — | $2.47M — | $128.1 — | $128.31 — | $8.29B — | 0 | -$2.51 — |
| Bio-Techne TECH | $52.8 — |
+1.75
|
$8.28B — | $2.3M — | $50.61 — | $53.41 — | $8.28B — | 63.61 | $0.83 — |
| Grifols, S.A. GRFS | $8.78 — |
+3.17
|
$7.32B — | $430.92K — | $8.67 — | $8.8 — | $7.32B — | 32.51 | $0.27 — |
| Repligen RGEN | $124.21 — |
+0.15
|
$6.98B — | $717.26K — | $121.99 — | $125.54 — | $6.98B — | 0 | -$0.42 — |
- {{ link.label }} {{link}}